Matthew B. Frieman

23.3k total citations · 7 hit papers
112 papers, 10.1k citations indexed

About

Matthew B. Frieman is a scholar working on Infectious Diseases, Immunology and Animal Science and Zoology. According to data from OpenAlex, Matthew B. Frieman has authored 112 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Infectious Diseases, 30 papers in Immunology and 26 papers in Animal Science and Zoology. Recurrent topics in Matthew B. Frieman's work include SARS-CoV-2 and COVID-19 Research (72 papers), COVID-19 Clinical Research Studies (29 papers) and Animal Virus Infections Studies (26 papers). Matthew B. Frieman is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (72 papers), COVID-19 Clinical Research Studies (29 papers) and Animal Virus Infections Studies (26 papers). Matthew B. Frieman collaborates with scholars based in United States, Canada and Netherlands. Matthew B. Frieman's co-authors include Christopher M. Coleman, Ralph S. Baric, Peter Palese, Sarah A. Kopecky-Bromberg, Thiagarajan Venkataraman, Mark T. Heise, Kirsten Kulcsar, Boyd L. Yount, Dipanjan Pan and Maha Alafeef and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Communications.

In The Last Decade

Matthew B. Frieman

110 papers receiving 9.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles

2020 589 citations Matthew B. Frieman et al. profile →
Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists

2006 531 citations Matthew B. Frieman et al. Journal of Virology profile →
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

2014 475 citations Julie Dyall, Christopher M. Coleman et al. Antimicrobial Agents and Chemotherapy profile →
Bats and Coronaviruses

2019 334 citations Matthew B. Frieman et al. profile →
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis

2014 307 citations Jason Kindrachuk, Brit J. Hart et al. Antimicrobial Agents and Chemotherapy profile →
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection

2019 247 citations Christopher M. Coleman, Sarah E. Beck et al. profile →
Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2

2021 200 citations James Logue, Matthew B. Frieman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew B. Frieman United States	55	7.0k	2.4k	1.8k	1.7k	1.2k	112	10.1k
M. Alejandra Tortorici United States	27	9.5k 1.3×	3.2k 1.3×	999 0.6×	1.8k 1.0×	1.0k 0.9×	40	11.6k
Yusen Zhou China	50	6.8k 1.0×	2.1k 0.9×	1.6k 0.9×	1.9k 1.1×	1.5k 1.3×	134	9.0k
Lu Lu China	51	6.6k 0.9×	3.1k 1.3×	1.9k 1.1×	1.1k 0.6×	1.6k 1.4×	305	11.8k
Peng Zhou China	42	6.3k 0.9×	1.6k 0.7×	1.1k 0.6×	1.1k 0.6×	1.6k 1.3×	172	10.4k
Xinquan Wang China	39	5.8k 0.8×	3.4k 1.4×	1.8k 1.0×	1.1k 0.6×	816 0.7×	134	10.3k
Andrew T. McGuire United States	25	6.3k 0.9×	2.7k 1.1×	1.7k 1.0×	773 0.4×	904 0.8×	51	9.2k
Alexandra C. Walls United States	26	9.5k 1.4×	3.8k 1.6×	972 0.6×	1.6k 0.9×	901 0.8×	32	11.9k
Benjamin W. Neuman United States	32	6.2k 0.9×	2.0k 0.8×	823 0.5×	1.3k 0.7×	659 0.6×	70	9.1k
Daniel Wrapp United States	17	7.0k 1.0×	2.6k 1.1×	928 0.5×	979 0.6×	1.0k 0.9×	26	9.1k
Young‐Jun Park United States	42	6.5k 0.9×	4.8k 2.0×	1.7k 1.0×	819 0.5×	993 0.8×	131	12.3k

Countries citing papers authored by Matthew B. Frieman

Since Specialization

Citations

This map shows the geographic impact of Matthew B. Frieman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Frieman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Frieman more than expected).

Fields of papers citing papers by Matthew B. Frieman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Frieman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Frieman. The network helps show where Matthew B. Frieman may publish in the future.

Co-authorship network of co-authors of Matthew B. Frieman

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Frieman. A scholar is included among the top collaborators of Matthew B. Frieman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Frieman. Matthew B. Frieman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Shaoming, Carly Dillen, Christina Schumacher, et al.. (2024). Association of Nirmatrelvir/Ritonavir Treatment and COVID-19-Neutralizing Antibody Titers in a Longitudinal Health Care Worker Cohort. Open Forum Infectious Diseases. 11(2). ofad625–ofad625. 1 indexed citations

Johnson, Robert M., Holly Hammond, James Logue, et al.. (2023). Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2. Journal of Virology. 97(11). e0133623–e0133623. 9 indexed citations

Jassey, Alagie, et al.. (2023). SIRT-1 is required for release of enveloped enteroviruses. eLife. 12. 3 indexed citations

Sunshine, Sara, Andreas S. Puschnik, Joseph M. Replogle, et al.. (2023). Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq. Nature Communications. 14(1). 6245–6245. 12 indexed citations

Li, Minghua, Kasirajan Ayyanathan, Mark Dittmar, et al.. (2023). SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. mBio. 14(4). e0119423–e0119423. 8 indexed citations

Jassey, Alagie, et al.. (2023). SIRT-1 is required for release of enveloped enteroviruses. eLife. 12. 1 indexed citations

Lai, Jianyu, Kristen K. Coleman, Sheldon Tai, et al.. (2022). Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants. Clinical Infectious Diseases. 76(5). 786–794. 30 indexed citations

Davenport, Bennett, Stuart Weston, Robert M. Johnson, et al.. (2022). Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease. npj Vaccines. 7(1). 57–57. 16 indexed citations

McGrath, Marisa E., Yong Xue, Carly Dillen, et al.. (2022). SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis. Proceedings of the National Academy of Sciences. 119(37). e2204717119–e2204717119. 33 indexed citations

10.

Koff, Wayne C., Tere Williams, Ralph S. Baric, et al.. (2021). Development and deployment of COVID-19 vaccines for those most vulnerable. Science Translational Medicine. 13(579). 51 indexed citations

11.

White, Judith M., Joshua T. Schiffer, Rachel Bender Ignacio, et al.. (2021). Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 12(6). e0334721–e0334721. 42 indexed citations

12.

Xiao, Jingyi, P. Jacob Bueno de Mesquita, Nancy Leung, et al.. (2021). Viral RNA and Infectious Influenza Virus on Mobile Phones of Patients With Influenza in Hong Kong and the United States. The Journal of Infectious Diseases. 224(10). 1730–1734. 3 indexed citations

13.

Funnell, Simon G. P., William E. Dowling, César Muñoz‐Fontela, et al.. (2020). Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nature Communications. 11(1). 4253–4253. 37 indexed citations

14.

Coleman, Christopher M., Jeanne M. Sisk, Gábor Halász, et al.. (2016). CD8 ⁺ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. Journal of Virology. 91(1). 46 indexed citations

15.

Pascal, Kristen E., Christopher M. Coleman, Alejandro O. Mujica, et al.. (2015). Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences. 112(28). 8738–8743. 172 indexed citations

16.

Kindrachuk, Jason, Brit J. Hart, Steven Mazur, et al.. (2014). Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis. Antimicrobial Agents and Chemotherapy. 59(2). 1088–1099. 307 indexed citations breakdown →

17.

Kim, Won‐Keun, Melissa D. Sánchez, Cynthia Koziol‐White, et al.. (2014). Deficiency of Melanoma Differentiation–associated Protein 5 Results in Exacerbated Chronic Postviral Lung Inflammation. American Journal of Respiratory and Critical Care Medicine. 189(4). 437–448. 19 indexed citations

18.

Coleman, Christopher M., Ye V. Liu, Justin Taylor, et al.. (2014). Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 32(26). 3169–3174. 226 indexed citations

19.

Frieman, Matthew B., Kiira Ratia, Robert E. Johnston, Andrew D. Mesecar, & Ralph S. Baric. (2009). Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling. Journal of Virology. 83(13). 6689–6705. 293 indexed citations

20.

Zupancic, Margaret L., Matthew B. Frieman, David F. Smith, et al.. (2008). Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Molecular Microbiology. 68(3). 547–559. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact